Abstract
The clinical efficacy of electrical algorithms for termination of slowventricular tachycardia (VT) and ventricular fibrillation (VF) inimplantable cardioverter-defibrillators (ICDs) is well established. Suchalgorithms have not been equally well defined for fast VT reversion. Wereport the testing of a prospectively designed algorithm for ICDs to treatfast VT that is inherently less responsive to antitachycardia pacing thanslow VT. Fourth-generation ICD devices were programmed to threeprospectively defined tachycardia detection zones as follows: cyclelengths≤ ms for VF, 270-330 ms for fast VT, and >330 ms for slow VT.The initial selected therapy for the VF zone was a high-energy biphasicshock (>15J), while a 3- or 5-J biphasic shock was usually administered forfast VT, and antitachycardia pacing was initially attempted for slow VT.Initial therapy was followed by backup therapy with high-energy shocks.Twenty-eight patients, 24 of whom were males, all with organic heartdisease, with a mean age of 65 ± 9 years, received either a Medtronic7219D (23 patients), 7219C (2 patients), 7218SP1 (2 patients), or 7218C (1patient) ICD with a nonthoracotomy lead system. The defibrillation thresholdwas 10 ± 5 J. At predischarge electrophysiologic testing, a single 3-or 5-J shock terminated all episodes of fast VT tested. During a follow-upof 18 ± 9 months, there were four nonarrhythmic deaths. Fourteenpatients (50%) had a total of 21 VF, 44 fast VT, and 202 slow VTepisodes. Twenty-three of 24 (96%) VF, 33 of 39 (84%) fast VT,and 193 of 202 (95.5%) slow VT episodes were terminated with thefirst delivered therapy in each therapy algorithm (p=NS). The overallefficacy of the entire electrical therapy algorithm was 100% for VF,100% for fast VT, and 98% for slow VT episodes (p=NS).No patient experienced syncope or presyncope during fast VT or VF in thisstudy. We conclude that a third detection and therapy zone can besuccessfully programmed in ICDs to define a range of fast VT episodes thatcan be effectively terminated with lower energy cardioversion shocks withcomparable success and freedom from arrhythmic symptoms to electricaltherapies used for slow VT and VF..
Similar content being viewed by others
References
Mirowski M, Reid PR, Watkins L, et al. Clinical treatment of life-threatening ventricular tachyarrhythmias with the automatic implantable defibrillator. Am Heart J 1981;102:265–270.
Saksena S, Poczobutt-Johanos M, Castle LW, et al. for the Guardian Multicenter Investigators Group. Long-term multicenter experience with a second-generation implantable pacemaker-defibrillator in patients with malignant ventricular tachyarrhythmias. J Am Coll Cardiol 1992;19:490–499.
Saksena, S. The PCD Investigator Group. Clinical outcome of patients with malignant ventricular tachyarrhythmias and a multiprogrammable cardioverter-defibrillator implanted with or without thoracotomy: An international multicenter study. J Am Coll Cardiol 1994;23:1521–1530.
Saksena S, Krol RB, Kaushik RR. Innovations in pulse generator and lead systems: Balancing complexity with clinical benefit and long-term results. Am Heart J 1994;127(Suppl): 1010–1021.
Jung W, Manz M, Luderitz B. New technology for implantable cardioverter-defibrillators: Capacitors, lead systems, shock waveforms. In: Saksena S, Luderitz B, eds. Interventional Electrophysiology 1996, 2nd ed. Armonk, NY: Futura, 1996:257–281.
Saksena S, Prakash A. Implantable cardioverter-defibrillators: Clinical results and patient selection. In: Saksena S, Luderitz B, eds. Interventional Electrophysiology 1996, 2nd ed. Armonk, NY: Futura, 1996:283–304.
Wyse DG, Kavanagh KM, Gillis AM. Comparison of biphasic and monophasic shocks for defibrillation using a nonthoracotomy system. Am J Cardiol 1993;71:197–202.
Swerdlow CD, Chen PS, Kass RM, et al. Discrimination of ventricular tachycardia from sinus tachycardia and atrial fibrillation in a tiered-therapy cardioverter-defibrillator. J Am Coll Cardiol 1994;23:1342–1355.
Gillberg JM, Olson WH, Bardy GH, et al. Electrogram width algorithm for discrimination of supraventricular rhythm from ventricular tachycardia (abstr). PACE 1994;17:866.
Lavergne T, Henry C, Ollitrault J, et al. Initial clinical experience with the first dual-chamber implantable cardioverter-defibrillator (abstr). PACE 1996;19:656.
Saksena S, Chandran P, Shah Y, et al. Comparative efficacy of transvenous cardioversion and pacing in patients with sustained ventricular tachycardia: A prospective, randomized, crossover study. Circulation 1985;72:153–160.
Bardy G, Poole J, Kudenchuk PJ, et al. A prospective randomized repeat crossover comparison of antitachycardia pacing with low energy cardioversion. Circulation 1993;87:1889–1896.
Saksena S, Luceri R, Krol RB, et al. Endocardial pacing, cardioversion and defibrillation using a braided endocardial lead system. Am J Cardiol 1993;71:834–841.
Saksena S, An H, Mehra R, et al. Prospective comparison of biphasic and monophasic shocks for implantable cardioverter-defibrillators using endocardial leads. Am J Cardiol 1992;70:304–310.
Fisher JD, Mehra R, Furman S. Termination of ventricular tachycardia with bursts of rapid ventricular pacing. Am J Cardiol 1978;41:94–102.
den Dulk K, Kersschot IE, Brugada P, et al. Is there a universal antitachycardia pacing mode? Am J Cardiol 1986;57:950–955.
Calvo RA, Saksena S, Pantopoulos D. Sequential transvenous pacing and shock therapy for termination of sustained ventricular tachycardia. Am Heart J 1988;115:569–575.
Ciccone JM, Saksena S, Shah Y, et al. A prospective randomized study of the clinical efficacy and safety of transvenous cardioversion for ventricular tachycardia termination. Circulation 1985;1:571–578.
Nathan AW, Bexton RS, Spurrell RA, et al. Internal transvenous low energy cardioversion for the treatment of cardiac arrhythmias. Br Heart J 1984;52:377–384.
Krol RB, Saksena S. Clinical trials of antiarrhythmic drugs in recipients of implantable cardioverter-defibrillators. In: Saksena S, Luderitz B, eds. Interventional Electrophysiology 1996, 2nd ed. Armonk, NY: Futura, 1996:365–375.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Neglia, J.J., Krol, R.B., Giorgberidze, I.S. et al. Evaluation of a Programming Algorithm for the Third Tachycardia Zone in a Fourth-Generation Implantable Cardioverter-Defibrillator. J Interv Card Electrophysiol 1, 49–56 (1997). https://doi.org/10.1023/A:1009766718942
Issue Date:
DOI: https://doi.org/10.1023/A:1009766718942